Japanese Retail Distributors Stock News

Mitsubishi UFJ Financial Group (TSE:8306) has drawn fresh attention after an interim audit review left its nine month Japanese GAAP results unchanged, while management reaffirmed a ¥2.1t full year profit target and a ¥74 per share dividend. See our latest analysis for Mitsubishi UFJ Financial Group. The earnings confirmation and guidance reiteration come after a strong run in the shares, with the 90 day share price return of 22.52% and a 1 year total shareholder return of 59.67% pointing to...

Unsurprisingly, Okamura Corporation's ( TSE:7994 ) stock price was strong on the back of its healthy earnings report...

The board of Fuso Chemical Co.,Ltd. ( TSE:4368 ) has announced that it will pay a dividend of ¥41.00 per share on the...

Columbia Works Inc. ( TSE:146A ) shareholders have had their patience rewarded with a 27% share price jump in the last...

Key Insights Significant control over OUG Holdings by retail investors implies that the general public has more power...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

IPS Holdings Co., Ltd. ( TSE:4335 ) just reported healthy earnings but the stock price didn't move much. Investors are...

A lackluster earnings announcement from Shinpo Co., Ltd. ( TSE:5903 ) last week didn't sink the stock price. However...

Food & Life Companies Ltd.'s ( TSE:3563 ) strong earnings report was rewarded with a positive stock price move. Our...

On February 12, 2026, Unicharm Corporation’s board approved a share repurchase program of up to 30,000,000 shares, or 1.72% of its capital, for ¥19,000 million running through December 17, 2026, following a prior downward revision of its 2025 earnings guidance due to weaker performance in China and Indonesia and impairment charges in Asia and India. This sequence of a profit warning and a sizeable buyback authorization highlights management’s focus on shareholder returns while addressing...

MatsukiyoCocokara recently issued earnings guidance for the year ending March 31, 2026, forecasting net sales of ¥1.10 trillion, operating profit of ¥85.50 billion, profit attributable to owners of parent of ¥56.50 billion and basic earnings per share of ¥141.67, alongside board-approved changes to representative directors and other senior roles effective April 1, 2026. By pairing a comprehensive leadership reshuffle with quantified profit and dividend confidence, the company is signaling an...

Latest FY 2025 Results Set the Stage for Suntory Beverage & Food Suntory Beverage & Food (TSE:2587) has just released its FY 2025 numbers, with fourth quarter revenue of ¥437.4 billion and basic EPS of ¥43.23, alongside trailing twelve month EPS of ¥287.13 on revenue of ¥1.72 trillion. Over recent periods, revenue has moved from ¥419.1 billion and EPS of ¥33.12 in Q4 2024 to ¥471.7 billion and EPS of ¥110.77 in Q3 2025, before settling at the latest Q4 levels. This gives investors a fresh...

Mitsubishi Materials (TSE:5711) Q3 2026 earnings snapshot Mitsubishi Materials (TSE:5711) has reported Q3 2026 revenue of ¥454.6b and basic EPS of ¥236.47, backed by net income of ¥30.9b for the quarter. The company’s revenue moved from ¥494.1b in Q3 2025 to ¥454.6b in Q3 2026, while quarterly EPS shifted from ¥187.54 to ¥236.47 over the same period, against a trailing twelve month EPS of ¥162.93 on revenue of ¥1.76t. This combination of a softer top line and firmer per share earnings focuses...

Inpex (TSE:1605) has just wrapped up FY 2025 with fourth quarter revenue of ¥490,704 million and basic EPS of ¥86.17, while trailing twelve month figures sit at ¥2.0 trillion in revenue and EPS of ¥337.94, giving investors a clear view of both the latest quarter and the full year run rate. Over recent periods, revenue has moved from ¥518,280 million and EPS of ¥115.17 in Q4 2024 to ¥490,704 million and EPS of ¥86.17 in Q4 2025, with trailing net profit margin at 19.6% compared with 18.9% a...

Sumitomo Pharma (TSE:4506) is back on investors’ radar after Japan’s Ministry of Health, Labour and Welfare scheduled a February 19 committee review of AMCHEPRY, its allogeneic iPS cell derived therapy for advanced Parkinson’s disease. See our latest analysis for Sumitomo Pharma. The upcoming AMCHEPRY review arrives after a volatile few months, with a 10.81% 7 day share price return and a 14.19% 30 day share price decline. At the same time, a very large 1 year total shareholder return of...

Nissan Motor recently revised its earnings guidance for the fiscal year ending March 31, 2026, now expecting net sales of ¥11,900,000 million, an operating loss of ¥60,000 million and a net loss of ¥650,000 million, largely reflecting faster fixed cost cuts under its Re:Nissan plan and lower foreign exchange headwinds. Although the projected net loss remains very large and is driven mainly by non‑cash restructuring and alignment charges, the sharply reduced operating loss forecast points to...

SoftBank Group shares move after recent performance SoftBank Group (TSE:9984) has drawn fresh attention after a mixed stretch, with a roughly 10% gain over the past week, a modest rise over the past month, and a decline over the past 3 months. See our latest analysis for SoftBank Group. At around ¥4,390 per share, SoftBank Group’s recent 1 day share price return of about 9% decline contrasts with a weaker 90 day share price return and a much stronger 1 year total shareholder return. This...

How Haseko's Latest Earnings Stack Up Against The Story So Far Haseko (TSE:1808) has reported another solid quarter, with Q3 2026 revenue of ¥297.6 billion and basic EPS of ¥52.88, set against trailing twelve month revenue of ¥1.23 trillion and EPS of ¥201.14 that reflect the 56.1% earnings growth highlighted over the past year. Over recent periods, revenue has ranged from ¥273.98 billion in Q2 2025 to ¥340.61 billion in Q4 2025, while quarterly EPS has moved between a loss of ¥3.68 in Q3...

Organo (TSE:6368) drew investor attention after reporting nine month earnings to December 31, 2025, with sales of ¥127,729 million and net income of ¥17,999 million, alongside fresh full year 2026 earnings guidance. See our latest analysis for Organo. The latest nine month earnings and fresh guidance appear to have caught the market’s attention, with Organo’s 1 day share price return of 2.32% and 7 day share price return of 9.76% contributing to a 1 year total shareholder return of 123.67%...

Daifuku Co., Ltd. recently issued consolidated earnings guidance for the interim and full fiscal year to December 31, 2026, and approved an increased year-end dividend of ¥44 per share for 2025, with guidance for a further rise to ¥46 per share in 2026. This combination of profit guidance and a clear commitment to gradually higher shareholder returns highlights how management is signaling confidence in the company’s earnings power and cash-generation capacity. We’ll now explore how Daifuku’s...

Why ITOCHU’s new buyback and earnings matter for shareholders ITOCHU (TSE:8001) has put a fresh share repurchase plan and a new earnings update on the table, giving you more detail on how management is handling cash and current profitability. On February 6, 2026, the board approved a buyback of up to 13,000,000 shares, equal to 0.2% of issued share capital, for up to ¥20,000 million, with the program running through March 31, 2026. This sits alongside recently reported nine month results to...

Electric Power Development (TSE:9513) is in focus after announcing a CEO transition related to health reasons and reporting mixed nine month results, with lower sales and revenue alongside higher net income and earnings per share. See our latest analysis for Electric Power Development. The CEO succession news comes on top of a solid run in the shares, with a 90 day share price return of 21.60% and a 1 year total shareholder return of 48.47%. This suggests momentum has been building rather...

MINEBEA MITSUMI Inc. has reported past nine‑month results to December 31, 2025, with sales rising to ¥1,232,235 million and net income to ¥49,385 million, alongside higher basic earnings per share from continuing operations. The company also lifted its full‑year March 2026 outlook, nudging up projected net sales and operating income while keeping profit attributable to owners unchanged, signaling management confidence in current business momentum. We’ll now examine how this firmer full‑year...

MEGMILK SNOW BRAND Co., Ltd. recently held its nine months 2026 earnings call on February 13, 2026, updating investors on the company’s latest financial and operational performance. The call offered fresh detail on how management is executing its current business plan and responding to recent industry conditions, providing investors with new context for assessing the company. We’ll now examine how the earnings call’s updated management commentary may influence MEGMILK SNOW BRAND’s broader...